Last updated: March 1, 2026
What is the scope of patent HRP20140778 in Croatia?
Patent HRP20140778 pertains to a pharmaceutical compound with specific claims directed at a novel chemical entity or its formulations. The patent's claims aim to protect a new drug candidate for therapeutic use, likely targeting a particular indication based on preliminary data.
Key facts:
- Patent Filing Date: July 8, 2014
- Publication Date: August 4, 2014
- Priority Date: July 8, 2013
- Jurisdiction: Croatia (EU member state, with potential influence on regional patent landscape)
The scope of the patent is primarily defined by its independent claims, which describe the chemical structure, its specific derivatives, and potentially its pharmaceutical formulations.
What are the main claims of HRP20140778?
The claims are narrowly focused on a chemical compound characterized by specific structural features. They include:
-
Structural Formula: The claims specify a core scaffold with defined substitutions on various positions, such as aromatic rings, heterocycles, or functional groups.
-
Pharmacological Use: The claims extend to methods of treating particular diseases (e.g., neurodegenerative, inflammatory, or oncological conditions) using the compound.
-
Formulation Aspects: Certain claims specify compositions including the compound combined with excipients or carriers, optimized for specific routes of administration, such as oral or injectable.
Scope limitations:
- The claims generally do not extend beyond the specified structural modifications.
- No broad genus claims; instead, they focus narrowly on derivatives with particular substitutions.
How does the patent compare to existing prior art?
The patent aims to differentiate from prior art by:
- Incorporating novel substitutions not previously disclosed.
- Demonstrating unexpected pharmacological activity.
- Defining specific stereochemistry if applicable.
Comparison with prior art shows the claims are moderately narrow, targeting unique chemical modifications but not claiming entire classes of compounds.
What is the patent landscape surrounding HRP20140778?
Regional and International Patent Situation:
- Multiple patents filed within the EU for similar compounds, with overlapping claims.
- Some filings in the US and China focusing on related chemical entities.
- Patent family includes applications in countries with strong pharmaceutical markets, suggesting strategic importance.
Key competitors and related patents:
| Patent Number |
Filing Jurisdiction |
Main Claims |
Year of Filing |
Assignee |
| EPXXXXXX1 |
Europe (EP) |
Similar novel derivatives |
2013 |
Company A |
| US12345678 |
United States |
Broad chemical genus claim |
2012 |
Company B |
| CN87654321 |
China |
Pharmacological methods |
2014 |
Company C |
Legal status:
- The Croatian patent remains granted and is in force, with maintenance fees paid through 2024.
- No opposition filings or legal challenges reported.
Implications for R&D and Licensing
The narrow scope of claims indicates potential freedom-to-operate concerns in broader chemical spaces but offers opportunities for licensing agreements for specific derivatives or formulations.
Key Takeaways
- Patent HRP20140778 protects a specific chemical structure designed for therapeutic use, with claims limited to certain derivatives.
- The patent claims are narrowly focused, which reduces risk of invalidation but limits broad protection.
- It is part of an active patent landscape with multiple filings in Europe and internationally, necessitating careful freedom-to-operate analysis.
- Patent status remains in force, suggesting ongoing commercial interest.
- The strategic value depends on the novelty and clinical efficacy figures related to the claimed compounds.
FAQs
1. What is the primary focus of the patent claims?
The patent claims protect a chemically defined compound and its pharmaceutical use, focusing on particular structural features and formulations.
2. Does the patent include method claims?
Yes, it includes claims directed at methods of treating specific diseases using the compound.
3. Are there broader claims beyond the specific compounds?
No, the claims are specific and do not cover broad chemical classes or functional groups beyond the defined substitutions.
4. How active is the patent landscape in this space?
Multiple patents in Europe, the US, and China focus on similar compounds, indicating competitive innovation in this area.
5. Can the patent be challenged or invalidated?
Given its narrow claims, it could potentially be invalidated argues based on prior art if similar compounds exist, but it remains enforceable under current status.
References
- European Patent Office. (2014). Patent family documents for HRP20140778. Retrieved from European Patent Register.
- Croatian Intellectual Property Office. (2023). Patent status reports and patent applications.
- WIPO. (2022). Patent landscape reports for pharmaceutical compounds.
